Prenetics Global Limited (PRENW)
USD 0.01
(3.23%)
USD 0.01
(3.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -52.51 Million USD | -125.32% |
| 2022 | 207.41 Million USD | 2104.32% |
| 2021 | -10.34 Million USD | -1169.66% |
| 2020 | 967.45 Thousand USD | 105.31% |
| 2019 | -18.22 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.9 Million USD | 18.71% |
| 2024 Q2 | -10.6 Million USD | -7.09% |
| 2023 Q1 | -12.04 Million USD | -195.12% |
| 2023 FY | -52.51 Million USD | -125.32% |
| 2023 Q3 | -13.67 Million USD | -12.41% |
| 2023 Q2 | -12.16 Million USD | -1.01% |
| 2023 Q4 | -12.18 Million USD | 10.88% |
| 2022 Q2 | -106.88 Million USD | -20390.34% |
| 2022 Q1 | -521.65 Thousand USD | 98.3% |
| 2022 Q4 | 12.66 Million USD | -36.57% |
| 2022 FY | 207.41 Million USD | 2104.32% |
| 2022 Q3 | 19.96 Million USD | 118.68% |
| 2021 Q2 | 14.81 Million USD | 34.03% |
| 2021 FY | -10.34 Million USD | -1169.66% |
| 2021 Q1 | 11.05 Million USD | 599.67% |
| 2021 Q4 | -30.75 Million USD | -475.92% |
| 2021 Q3 | -5.33 Million USD | -136.03% |
| 2020 Q2 | -1.58 Million USD | 53.0% |
| 2020 Q1 | -3.38 Million USD | 0.0% |
| 2020 FY | 967.45 Thousand USD | 105.31% |
| 2020 Q4 | -2.21 Million USD | -128.92% |
| 2020 Q3 | 7.65 Million USD | 581.34% |
| 2019 FY | -18.22 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 46.061% |
| Biodesix, Inc. | -41.34 Million USD | -27.022% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -558.623% |
| Castle Biosciences, Inc. | -67.97 Million USD | 22.748% |
| DarioHealth Corp. | -56.18 Million USD | 6.541% |
| Exact Sciences Corporation | -215.01 Million USD | 75.576% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 104.786% |
| Illumina, Inc. | -1.06 Billion USD | 95.088% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -410.675% |
| iSpecimen Inc. | -11.16 Million USD | -370.158% |
| Standard BioTools Inc. | -76.6 Million USD | 31.444% |
| 23andMe Holding Co. | -321.35 Million USD | 83.659% |
| Medpace Holdings, Inc. | 336.82 Million USD | 115.591% |
| NeoGenomics, Inc. | -107.73 Million USD | 51.257% |
| Inotiv, Inc. | -81.46 Million USD | 35.535% |
| Psychemedics Corporation | -2.92 Million USD | -1697.794% |
| Precipio, Inc. | -7.62 Million USD | -589.154% |
| RadNet, Inc. | 98.69 Million USD | 153.207% |
| Sotera Health Company | 276.69 Million USD | 118.979% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -1108.319% |
| Exagen Inc. | -22.83 Million USD | -129.949% |
| Natera, Inc. | -446.24 Million USD | 88.232% |
| Aspira Women's Health Inc. | -18.85 Million USD | -178.557% |
| Neogen Corporation | 58.66 Million USD | 189.517% |
| Myriad Genetics, Inc. | -123.7 Million USD | 57.548% |
| ICON Public Limited Company | 956.15 Million USD | 105.492% |
| Bionano Genomics, Inc. | -215.24 Million USD | 75.603% |
| CareDx, Inc | -101.9 Million USD | 48.466% |
| Check-Cap Ltd. | -19.28 Million USD | -172.274% |
| Twist Bioscience Corporation | -220.83 Million USD | 76.22% |
| Guardant Health, Inc. | -564.72 Million USD | 90.701% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -1924.745% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 27.762% |
| Sera Prognostics, Inc. | -39.82 Million USD | -31.874% |
| OPKO Health, Inc. | -157.02 Million USD | 66.556% |
| Personalis, Inc. | -109.93 Million USD | 52.233% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -379.432% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -1108.319% |
| MDxHealth SA | -27.32 Million USD | -92.167% |
| Prenetics Global Limited | -52.51 Million USD | -0.0% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -399.143% |
| Mainz Biomed B.V. | -26.64 Million USD | -97.088% |
| Trinity Biotech plc | -27.04 Million USD | -94.171% |
| Neuronetics, Inc. | -30.55 Million USD | -71.871% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -558.623% |